Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

BACKGROUND: Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson’s disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before the manifestation of the clinical symptoms, point...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Neurodegener
Autori principali: Majbour, Nour K., Vaikath, Nishant N., van Dijk, Karin D., Ardah, Mustafa T., Varghese, Shiji, Vesterager, Louise B., Montezinho, Liliana P., Poole, Stephen, Safieh-Garabedian, Bared, Tokuda, Takahiko, Teunissen, Charlotte E., Berendse, Henk W., van de Berg, Wilma D. J., El-Agnaf, Omar M. A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717559/
https://ncbi.nlm.nih.gov/pubmed/26782965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-016-0072-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi